the changing landscape - self care forum · 3% 7% 15% 15% 1% 12% 0% 10% 20% 30% 40% 50% taking...
TRANSCRIPT
Confidential & Proprietary • Copyright © 2009 The Nielsen Company
The Changing Landscape – A Multi-Country Study Undertaken with AESGP
Online Survey In 50 Countries Fieldwork March/April 2009
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Research Objective
• The Nielsen Company has partnered with The Association Of The European Self-Medication Industry (AESGP) in a global research project with the objective of better understanding consumer attitudes towards key aspects of self-care
1. Willingness to self-medicate when feeling the onset of a minor ailment
2. Barriers to routine self-medication when feeling the onset of a minor ailment
3. Factors influencing product choice of non-prescription medicines
4. Impact of current global economic slowdown on usage of Self Medication
5. Primary route for knowledge that enables responsible usage of Self Medication products
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Research Scope & Method
• Online questionnaire in 50 countries– Reflects internet-connected population: key to bear this in mind when interpreting results from countries with
relatively low internet household penetration
– Note: definition of “internet-connected” is all those who have access to the internet at home and/or at work
– Questionnaire put forward in local language (not English) where relevant
• Sample sizes– Approximately 500 for all countries except......
– Over 25,000 respondents globally
• Sample representation– Structured around gender and age (15+) of internet-connected population by country
– At a global level for gender representation: male 55%, female 45%
– At a global level for age representation: skewed to younger age groups (54% of respondents aged 15-34)
• Global and regional averages are “weighted” for internet population and are not “numeric” averages– See map for participating countries and regional groupings
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
North America:CanadaUSA
Latin America:MexicoBrazilArgentinaChileColombiaVenezuela
Middle East & Africa:TurkeyIsraelSaudi ArabiaUAESouth Africa
Asia PacificAustraliaNew ZealandChinaHong KongIndia PakistanIndonesiaJapanSouth KoreaMalaysia
PhilippinesSingaporeThailandTaiwan Vietnam
EuropeAustria, Belgium, Denmark, Finland, France, Germany , Greece, Ireland, Italy, Netherlands,Norway, Portugal, Spain, Sweden, Switzerland, Unite d Kingdom, Poland, Russia, Czech Republic, Hungary, Estonia, Latvia
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Analysis Commentary –Issues To Consider When Interpreting Results
• All interviews were undertaken on-line, with respondents self-completing the questionnaire
– Respondents reflect the internet-connected population by country, and samples are determined by age and gender demographics
• No prompting was given to respondents – questions were answered in the way that respondents understood them
• No guidance was given to respondents about.....– The definition of a minor ailment
– The definition of a non-prescription medicine
– How many responses to give on question 3, where multiple responses were allowed
• On the following slides, the global aggregate data is provided with interpretation to act as a framework for data users
– Whist it is understood that data interpretation has some degree of subjectivity, it is recommended that all results are viewed as indicative of consumer sentiment and evaluated in good faith and not used as definitive proof in support of a particular issue
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Executive Summary – Main Findings From Global Results
• Questions 1 & 2• When feeling the first signs of a “minor ailment”, 33% of all respondents globally indicated that they would
“always” or “usually” take a medicine as soon as they started to feel unwell. • 95% of respondents are open to the concept of taking medicines to treat minor ailments. • Of those who usually wait to see if a minor ailment gets better before taking a medicine or never take a
medicine, 47% consider that taking medication can be harmful. This perception may be a barrier to self care; it also indicates, however, that there is a high level of awareness of the importance of using all medication safely and with respect for the instructions.
• Only a small number of those who usually wait to see if a minor ailment gets better before taking a medicine or never take a medicine, consider access, price or efficacy to be a reason for not taking a medicine.
• Question 3• Safety and efficacy are the most important product choice attributes that consumers have globally for non-
prescription medicines. • A number of attributes form a secondary core to purchase choice, including the advice of the pharmacist,
speed of action and issues around confidence, loyalty and trust
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Executive Summary – Main Findings From Global Results
• Questions 4 & 5• 46% of consumers globally claimed that their usage of non-prescription medicines would change in the
coming year as a result of the global financial crisis • Of those agreeing that their usage would change, the main ways this would manifest itself was in less
frequent use of the products and a move to usage of more natural & traditional remedies• Only 6% of those agreeing that their usage would change indicated that they would stop buying the
products.
• Question 6• There is no clear global consensus from consumers on the way in which they ensure safe and responsible
usage of medicines• A three way split of opinion exists across reading the product information leaflet, reading the on-pack
instructions and asking the pharmacist
• All questions• The global averages clearly mask the local country-specific similarities and differences• Local regulatory frameworks, distribution policies and other environmental factors influence consumers, and
these should be borne in mind when interpreting all results from this research
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q1. When you feel the first signs of a minor ailment starting, which of the following applies to you? 50 Country Global Average
10%
23%
62%
5%
0%
10%
20%
30%
40%
50%
60%
70% (A) I always take a medicineas soon as I start to feelunwell
(B) I usually take a medicineas soon as I start to feelunwell
(C) I usually wait to see if itgets better before taking medicine
(D) I never take medicine
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents globally
(A) (B) (C) (D)
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q2. If you “usually wait to see” or “never take medicine” (Q1), what is the main reason that you would not take medicine? Note: Question asked only to those responding to question 1 with response C or D
50 Country Global Average
47%
3%
7%
15%
15%
1%
12%
0% 10% 20% 30% 40% 50%
Taking medicines can be harmful to your health
Medicines do not work
Medicines are too expensive
I would visit the doctor for advice
I use other methods of treatment
Access to medicines is too difficult
Other
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents globally:
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q3. When choosing a non-prescription medicine, what factors are important to you?50 Country Global Average
24%
14%
37%
36%
18%
26%
4%
8%
26%
27%
26%
13%
0% 10% 20% 30% 40%
A name that I trust
It is value for money
I know it is safe
I know it works
The price
I know it works quickly
The advertising for the product
It is easy to take
I have confidence in the product
The advice of the pharmacist
It is the one I usually use
The product is recognisable
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide
Multiple responses permitted, so aggregate exceeds 100%
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q4. In the next year, do you expect that the global financial crisis will affect the amount of, or type of non-prescription medicines that you will use?50 Country Global Average
46%
54%
0% 10% 20% 30% 40% 50% 60%
Yes
No
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q5. What do you think will be the main way your usage of non-prescription medicines will change? Note: Question asked only to those responding “yes” to question 450 Country Global Average
6%
26%
11%
8%
10%
14%
19%
5%
0% 10% 20% 30%
I will stop buying them
I will use them less frequently
I will continue to use them, but will sometimes use less than therecommended dosage
I will buy smaller pack sizes
I will buy cheaper products
I will visit the doctor more instead of buying them
I will use more natural and traditional remedies
I will buy more products that will help prevent me getting ill
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: asked of those responding “yes” to question 4: - subset of 25,000+ respondents worldwide
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q6. Which of the following statements best reflects how you ensure you use a non-prescription medicine responsibly?50 Country Global Average
26%
24%28%
6%
15%
I ask the pharmacist foradvice on how to use theproductI read the productinformation leaflet in thepackI read the usageinstructions on the pack
I look up the usageinstructions on the internet
I make my own decisionbased on previousexperience
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
EuropeAustria, Belgium, Denmark, Finland, France, Germany , Greece, Ireland, Italy, Netherlands,Norway, Portugal, Spain, Sweden, Switzerland, Unite d Kingdom, Poland, Russia, Czech Republic, Hungary, Estonia, Latvia, Lithuania
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q1. When you feel the first signs of a minor ailment starting, which of the following applies to you? 22 Country Europe Average
7%
18%
67%
8%
0%
10%
20%
30%
40%
50%
60%
70% (A) I always take a medicineas soon as I start to feelunwell
(B) I usually take a medicineas soon as I start to feelunwell
(C) I usually wait to see if itgets better before taking medicine
(D) I never take medicine
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents globally
(A) (B) (C) (D)
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q1. When you feel the first signs of a minor ailment starting, which of the following applies to you? Europe - (A) I always take a medicine as soon as I start to feel unwell
3%4%
2%3%
9%
5%
7% 7%
3% 3%
10%
4%
8%
2%
4%
10%
5%
2%
6%7%
5%
8%
0%
10%
20%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q1. When you feel the first signs of a minor ailment starting, which of the following applies to you? Europe - (B) I usually take a medicine as soon as I start to feel unwell
13% 14%
8%
11%
23%
12%
16%14% 13%
11%
28%
16%
29%
14%16%
22%
18%
10%12%
21% 22% 23%
0%
10%
20%
30%
40%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q1. When you feel the first signs of a minor ailment starting, which of the following applies to you? Europe - (C) I usually wait and see if it gets better before taking a medicine
67%
78%73% 73% 74%
61%
76%70% 72%
66%
73%
55%
75%
58%
77%72%
60%
69%75%
71%67%
64%60%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q1. When you feel the first signs of a minor ailment starting, which of the following applies to you? Europe - (D) I never take a medicine
8%7%
9%
17%
12%
7% 7%6%
7%
17%
14%
7%
5% 5%
7%8% 8%
7%
13%
11%
5%
9% 9%
0%
10%
20%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q2. If you “usually wait to see” or “never take medicine” (Q1), what is the main reason that you would not take medicine? 22 Country Europe Average
43%
3%
6%
18%
18%
1%
12%
0% 10% 20% 30% 40% 50%
Taking medicines can be harmful to your health
Medicines do not work
Medicines are too expensive
I would visit the doctor for advice
I use other methods of treatment
Access to medicines is too difficult
Other
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide - asked only to th ose who responded (C) & (D) for question 1
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q2. If you “usually wait to see” or “never take medicine” (Q1), what is the main reason that you would not take medicine? Europe – Taking medicines can be harmful to your health
31%
42%
59%
45%
38% 37%
45%
56%
38%
46% 48% 46%
37%42%
31%
38% 37%
45% 43%
58%
44% 43%
0%
10%
20%
30%
40%
50%
60%
70%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide - asked only to th ose who responded (C) & (D) for question 1
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q2. If you “usually wait to see” or “never take medicine” (Q1), what is the main reason that you would not take medicine? Europe – Medicines do not work
1%
2% 2%
6%
3%
1%
2%
1%
2%
4%
3%
1% 1%
4%
2%
7%
2% 2% 2%
3%
2%
3%
0%
10%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide - asked only to th ose who responded (C) & (D) for question 1
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q2. If you “usually wait to see” or “never take medicine” (Q1), what is the main reason that you would not take medicine? Europe – Medicines are too expensive
4%
6%
1%
5%6%
11%10%
3%
1%
5%
7%
3%
1%
5%
7%
10%
5%4%
1%2%
9%
6%
0%
10%
20%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide - asked only to th ose who responded (C) & (D) for question 1
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q2. If you “usually wait to see” or “never take medicine” (Q1), what is the main reason that you would not take medicine? Europe – I would visit the doctor for advice
17%
29%
14%
5%
24%
10%13%
22%
26%
16%
21%
29%
41%
13%11%
14% 14%
10%
35%
6%
10% 9%
0%
10%
20%
30%
40%
50%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide - asked only to th ose who responded (C) & (D) for question 1
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q2. If you “usually wait to see” or “never take medicine” (Q1), what is the main reason that you would not take medicine? Europe – I use other methods of treatment
37%
8%6%
20%
11%
32%
19%
11%
6% 7%
16%
11%9%
11%
33%
11%
31% 32%
16%
24%26%
35%
0%
10%
20%
30%
40%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide - asked only to th ose who responded (C) & (D) for question 1
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q2. If you “usually wait to see” or “never take medicine” (Q1), what is the main reason that you would not take medicine? Europe – Access to medicines is too difficult
0%
1%
0% 0%
1%
0%
1% 1%
0% 0% 0%
1%
3%
1% 1% 1% 1%
0% 0% 0% 0% 0%0%
10%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide - asked only to th ose who responded (C) & (D) for question 1
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q2. If you “usually wait to see” or “never take medicine” (Q1), what is the main reason that you would not take medicine? Europe – Other reasons
9%
13%
18% 18% 18%
10%11%
6%
27%
22%
4%
9% 9%
24%
15%
19%
10%
7%
3%
7%8%
5%
0%
10%
20%
30%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide - asked only to th ose who responded (C) & (D) for question 1
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q3. When choosing a non-prescription medicine, what factors are important to you?22 Country Europe Average
13%
15%
28%
43%
15%
25%
2%
9%
26%
38%
26%
9%
0% 10% 20% 30% 40% 50%
A name that I trust
It is value for money
I know it is safe
I know it works
The price
I know it works quickly
The advertising for the product
It is easy to take
I have confidence in the product
The advice of the pharmacist
It is the one I usually use
The product is recognisable
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide
Multiple responses permitted, so aggregate exceeds 100%
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q3. When choosing a non-prescription medicine, what factors are important to you?Europe – A name that I trust
7%
13%
23%
12%
9%8%
22%
17%19%
13%
9%
20%
6%
19%
13%
18%
8%
11%
7%
19%
9%
17%
0%
10%
20%
30%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide
% of respondents choosing this option – more than one option could be chosen
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q3. When choosing a non-prescription medicine, what factors are important to you?Europe – It is value for money
15%
9%11%
31%
11%
29%
10%7%
4% 3%
18%
13%
9%11%
20% 21%
3%
19%
4%
12%
26%
10%
0%
10%
20%
30%
40%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide
% of respondents choosing this option – more than one option could be chosen
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q3. When choosing a non-prescription medicine, what factors are important to you?Europe – I know it is safe
32%
24%
35%32%
21%
29%
40%
23%
34% 33%35%
30% 31%
22%25%
33%
19%
24%
48%
20%17%
19%
0%
10%
20%
30%
40%
50%
60%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide
% of respondents choosing this option – more than one option could be chosen
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q3. When choosing a non-prescription medicine, what factors are important to you?Europe – I know it works
46% 45%49% 50%
46%
40% 40%36%
42%
48%
37%
28%
49% 49%
44%41%
45%
50%53%
47%44%
36%
0%
10%
20%
30%
40%
50%
60%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide
% of respondents choosing this option – more than one option could be chosen
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q3. When choosing a non-prescription medicine, what factors are important to you?Europe – The price
9%11%
13%
23%
10%
20%
14%
11%
15%
18%17%
20%
6%
21%
13%
27%
23%
16%
6%
10%
16%18%
0%
10%
20%
30%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide
% of respondents choosing this option – more than one option could be chosen
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q3. When choosing a non-prescription medicine, what factors are important to you?Europe – I know it works quickly
28%25%
16%
23%
29% 30% 30%
25% 25%
20%
26%
20%
16%
25%
34%
27%
33%
21%
17%15%
24%
12%
0%
10%
20%
30%
40%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide
% of respondents choosing this option – more than one option could be chosen
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q3. When choosing a non-prescription medicine, what factors are important to you?Europe – The advertising for the product
0%
1%
3%
1% 1% 1% 1%
3%
1% 1%
4%
2%
1%
2%
1% 1%
3% 3%
2%
6%
2% 2%
0%
10%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide
% of respondents choosing this option – more than one option could be chosen
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q3. When choosing a non-prescription medicine, what factors are important to you?Europe – It is easy to take
8%
6%
8%
6%7%
10%11%
9%
7%
11%
7%
5%
7%
10% 10%
17%
7%
3%
5%
7%8%
5%
0%
10%
20%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide
% of respondents choosing this option – more than one option could be chosen
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q3. When choosing a non-prescription medicine, what factors are important to you?Europe – I have confidence in the product
35%
27%
42%
29%
22%
28%30%
15%
26%
30% 30%
35%
28%
33%31%
29%26%
21%24% 23%
25%27%
0%
10%
20%
30%
40%
50%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide
% of respondents choosing this option – more than one option could be chosen
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q3. When choosing a non-prescription medicine, what factors are important to you?Europe – The advice of the pharmacist
42%
53%
34%
27%
46%
29%
41%
46%
34%
41%38%
49%52%
34%37%
29%
44%42%
46%
27%
43%
35%
0%
10%
20%
30%
40%
50%
60%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide
% of respondents choosing this option – more than one option could be chosen
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q3. When choosing a non-prescription medicine, what factors are important to you?Europe – It is the one I usually use
15%
31%
20%
29%
37%
10%
19%
24%27%
32%35% 34%
31% 30% 29%
16%
43%
28%
35%
39%
35%
29%
0%
10%
20%
30%
40%
50%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide
% of respondents choosing this option – more than one option could be chosen
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q3. When choosing a non-prescription medicine, what factors are important to you?Europe – The product is recognisable
2% 2%
7%
22%
3%1%
10% 9% 9%
5% 6%4% 5%
10%
3%
8%
2% 3%
13%
40%
14%
35%
0%
10%
20%
30%
40%
50%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide
% of respondents choosing this option – more than one option could be chosen
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q4. In the next year, do you expect that the global financial crisis will affect the amount of, or type of non-prescription medicines that you will use? – Europe average: Yes = 33%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Yes No
No 78% 69% 95% 87% 55% 75% 69% 53% 84% 93% 68% 57% 68% 82% 80% 75% 60% 50% 49% 50% 64% 42%
Yes 22% 31% 5% 13% 45% 25% 31% 47% 16% 7% 32% 43% 32% 18% 20% 25% 40% 50% 51% 50% 36% 58%
AU BE DK FI FR DE IRL IT NL NO PL PT ES SWE CH UK CZ HU GR RUS EST LAT
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q5. What do you think will be the main way your usage of non-prescription medicines will change? Note: Question asked only to those responding “yes” to question 422 Country Europe Average
5%
26%
8%
8%
16%
13%
18%
6%
0% 10% 20% 30%
I will stop buying them
I will use them less frequently
I will continue to use them, but will sometimes use less than therecommended dosage
I will buy smaller pack sizes
I will buy cheaper products
I will visit the doctor more instead of buying them
I will use more natural and traditional remedies
I will buy more products that will help prevent me getting ill
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide - asked only to th ose who responded “yes” to question 4
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q5. What do you think will be the main way your usage of non-prescription medicines will change? Note: Question asked only to those responding “yes” to question 4Europe – I will stop buying them
2%3%
0%
4%
10%
3%
9%
2%
4%3%
6%
1%
6%5% 5%
11%
4% 4%
6%
2%
11%
4%
0%
10%
20%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide - asked only to th ose who responded “yes” to question 4
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q5. What do you think will be the main way your usage of non-prescription medicines will change? Note: Question asked only to those responding “yes” to question 4Europe – I will use them less frequently
24% 25%23%
19%
25%27%
38%
28%
17%
28%30%
20%
29%31%
20%
34%
22%
18%
33%
19%
27%
17%
0%
10%
20%
30%
40%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide - asked only to th ose who responded “yes” to question 4
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q5. What do you think will be the main way your usage of non-prescription medicines will change? Note: Question asked only to those responding “yes” to question 4Europe – I will continue to use them, but will sometimes use less than the recommended dose
8%
5%
3%
14%
6%
10%
8%
6%
13%
19%
6%
8% 8%
17%
5%
8%
6% 6%
8%
13%
5%
8%
0%
10%
20%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide - asked only to th ose who responded “yes” to question 4
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q5. What do you think will be the main way your usage of non-prescription medicines will change? Note: Question asked only to those responding “yes” to question 4Europe – I will buy smaller pack sizes
5%
11%
0%1%
10%
4%5%
9%
14%12%
10%
20%
5%
8%
11%
5%6%
13%
5%6%
3%
6%
0%
10%
20%
30%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide - asked only to th ose who responded “yes” to question 4
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q5. What do you think will be the main way your usage of non-prescription medicines will change? Note: Question asked only to those responding “yes” to question 4Europe – I will buy cheaper products
17%
23%25%
43%
9%
24%
13%16%
9%
21%19% 18%
14%
23% 22%19%
9% 10%
4%
13%
8% 9%
0%
10%
20%
30%
40%
50%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide - asked only to th ose who responded “yes” to question 4
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q5. What do you think will be the main way your usage of non-prescription medicines will change? Note: Question asked only to those responding “yes” to question 4Europe – I will visit the doctor more instead of buying them
21%
9%
38%
2%
15% 15%
5%
18%
25%
8%
4%
9%
28%
1%
8%
13%
5%2%
15%
2%4%
0%0%
10%
20%
30%
40%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide - asked only to th ose who responded “yes” to question 4
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q5. What do you think will be the main way your usage of non-prescription medicines will change? Note: Question asked only to those responding “yes” to question 4Europe – I will use more natural and traditional remedies
22% 22%
8% 9%
19%
15% 16%18%
9%7%
15%
20%
5%
9%
26%
8%
30%
36%
20%
31% 32%
42%
0%
10%
20%
30%
40%
50%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide - asked only to th ose who responded “yes” to question 4
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q5. What do you think will be the main way your usage of non-prescription medicines will change? Note: Question asked only to those responding “yes” to question 4Europe – I will buy more products that help prevent me getting ill
1%2%
4%
8%
5%
3%
5%
3%
9%
2%
9%
5%4%
6%
3%2%
16%
10%9%
13%
11%
13%
0%
10%
20%
Austria
Belgium
Denm
ark
Finland
France
Germ
any
Ireland
Italy
Netherlands
Norw
ay
Poland
Portugal
Spain
Sw
eden
Sw
itzerland
UK
Czech
Hungary
Greece
Russia
Estonia
Latvia
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide - asked only to th ose who responded “yes” to question 4
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q6. Which of the following statements best reflects how you ensure you use a non-prescription medicine responsibly?22 Country Europe Average
29%
32%
16%
6%
17%
I ask the pharmacist foradvice on how to use theproductI read the productinformation leaflet in thepackI read the usageinstructions on the pack
I look up the usageinstructions on the internet
I make my own decisionbased on previousexperience
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide
Confidential & ProprietaryCopyright © 2009 The Nielsen Company
Q6. Which of the following statements best reflects how you ensure you use a non-prescription medicine responsibly? - Europe by country
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
E 13% 17% 15% 24% 19% 18% 16% 14% 27% 23% 17% 6% 13% 20% 18% 18% 13% 16% 12% 16% 15% 20%
D 3% 3% 2% 3% 6% 6% 4% 4% 4% 3% 6% 3% 2% 6% 5% 3% 5% 14% 3% 15% 4% 12%
C 11% 9% 23% 23% 14% 13% 25% 14% 16% 20% 9% 17% 13% 20% 13% 35% 11% 12% 7% 11% 13% 9%
B 44% 26% 37% 20% 18% 34% 30% 37% 35% 29% 44% 29% 28% 30% 36% 28% 44% 23% 41% 38% 40% 25%
A 28% 44% 23% 29% 43% 28% 26% 31% 18% 25% 25% 46% 45% 24% 29% 16% 27% 34% 37% 20% 28% 34%
AU BE DK FI FR DE IRL IT NL NO PL PT ES SWE CH UK CZ HU GR RUS EST LAT
Source: ACNielsen Global On-Line Omnibus Mar/Apr 20 09: 25,000+ respondents worldwide
A: I ask the pharmacist for advice on how to use the product B: I read the product information leaflet in the packC: I read the usage instructions on the pack D: I look up the usage instructions on the internetE: I make my own decision based on previous experience
E
DC
B
A